Vancouver, B.C., Jan. 03, 2020 (GLOBE NEWSWIRE) -- Vancouver, BC, January 3, 2020 - INVICTUS MD STRATEGIES CORP. ("Invictus" or the "Company") (TSXV: GENE; OTCQX: IVITF; FRA: 8IS2) further to the Company’s news release dated December 16, 2019, the Company has terminated the binding letter of intent with Unified Cannabis Corp. of Calgary, Alberta in respect of the proposed $5.7 million convertible debenture financing.
For more information, please visit www.invictus-md.com.
Marc Ripa